2024 is a pivotal year for the US healthcare sector. America remains a global leader in life sciences investment and innovation, but access to healthcare in the US is uneven, regulations are uncertain, and the presidential election poses risks to Pharma.  ​

  • What can stakeholders do to address falling life expectancy in the US?​

  • How is AI being plugged into discovery models?​

  • Are pharma workforces ready for a new generation of American talent?​

The Financial Times US Pharma and Biotech Summit returns to New York in May 2024, partnered with Endpoints News for the first time. Gathering leaders and experts in areas such as drug discovery, clinical development and market access to share insights and connect with each other. ​

As part of the New York Bio community, you can save 20% off on your in-person and digital pass with discount code NYBIO: https://bit.ly/4aH3Vtw #FTPharma​


Savings Partners